Management options for vulvar carcinoma in a low resource setting by Eke, Ahizechukwu C et al.
RESEARCH Open Access
Management options for vulvar carcinoma in a
low resource setting
Ahizechukwu C Eke
1*, Lilian I Alabi-Isama
2, Josephat C Akabuike
1
Abstract
Background: Vulvar carcinoma is a rare tumor of the female genital tract. In Nigeria, very few studies have looked
at the management options for vulvar carcinoma. The objective of this study was therefore, to describe the
management options available and the challenges in treating this malignancy in Nigeria.
Methods: A descriptive study of all vulvar cancer cases managed at the Nnamdi Azikiwe University Teaching
Hospital, Nnewi over a 12 year period (1998-2009). The theatre, ward register, histo-pathologic records and case
notes of all women who had surgery for vulvar carcinomas were retrieved and socio-demographic characteristics,
clinical presentation, type of surgery, histologic type and complications of treatment were retrieved and analyzed.
Results: There were 867 gynecological malignancies and vulval carcinoma accounted for 11 cases, giving a
prevalence of 1.27%. The ages ranged from 54 to 79 years with a mean of 61.2 years. Parity was 2-14, with a mean
of 6.7± 2.33. Most of the patients were of low socio-economic class. All the 11 patients had surgery as 1
st line
treatment. Radical vulvectomy was done for 6 cases since they presented in the advanced stage. The
complications of surgery included hemorrhage (18.2%), chronic lymphedema, wound infection and anesthetic
complications. There were no hospital mortalities. Late presentation, with stage III (45.4%) was the commonest
stage at presentation while the majority of the vulvar carcinomas (72.7%) were of epithelial origin. Squamous cell
carcinoma predominated (63.6%).
Conclusion: Carcinoma of the vulva is a rare gynecological malignancy in Nigeria. Surgery and radiotherapy
remains the mainstay of this disease in Nigeria and can be highly successful if patients present early.
Background
Vulvar cancer is one of the rarest gynecological cancers
in Nigeria [1]. In a study in Zaria, Nigeria, it accounted
for 1.2% of all genital tract malignancies [1]. It affects 3
in 100,000 women per year and accounts for 4% of
female genital tract malignancies in the United Kingdom
[2]. It is a disease of older women, with over 80% of cases
occurring in women over 55 years old (between the ages
of 60-70) [2,3]. Up to 15% of vulvar cancers are diag-
nosed in women under 40 years old [2,3]. Possibly due to
human papilloma virus infections, clinicians are treating
increasing numbers of younger women, which presents
unique challenges in managing this cancer [1-3].
Carcinoma of the vulva may arise from the skin, subcu-
taneous tissue, glandular elements of the vulva or the
epithelium of the lower third of the vagina [4]. Of all the
vulval carcinomas, 1-2% are basal cell carcinomas, with
the majority being squamous cell carcinomas (90%) [2,4].
Less common primary cancers are malignant melanomas,
carcinoma of Bartholin’s gland, sarcomas, Paget’s disease
of the vulva and sweat gland cancers [4,5]. Although vul-
var carcinoma is more common in the elderly in most
parts of the world, the incidence is rising in all age
groups [4]. A study done in Nigeria 20 years ago showed
that vulvar carcinoma was commoner among women of
low socio-economic status [6]. It is primarily a disease of
post-menopausal women, with peak incidence in women
aged 60-70 years [4,6].
Despite the advanced age of many of these patients
and the frequent finding of a moderately large tumor,
the disease is usually amenable to surgical and radiation
therapy. In stages I and II disease, the corrected 5 year
survival rate is greater than 90% [1,4].
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radical vulvectomy with superficial and deep inguinal node
dissection through a single incision with at least 2-cm
margins around the tumor [4]. Treatment of advanced
cases of vulvar cancer is usually followed by adjuvant
radiotherapy for most patients [4]. Surgical approaches in
the treatment of vulvar cancer have changed significantly
over time because of the significant peri-operative morbid-
ity and mortality from radical vulvar surgeries. More con-
servative operative approaches are used today that have
fewer complications and are less disfiguring than the radi-
cal vulvectomy and bilateral inguinal node dissection
commonly practiced in the past. These conservative
approaches include unilateral inguinal node dissection for
small ipsilateral tumors, the triple-incision technique, wide
local excision with 1-cm margins, and saphenous vein
sparing surgeries, with attempts made to prevent lymphe-
dema [4].
The objective of this study was to describe the man-
agement options for vulvar carcinoma available in
Nigeria, and the challenges encountered in the manage-
ment of these vulvar malignancies.
Methods
This was a descriptive study of all cases of vulvar carci-
noma that presented to the Nnamdi Azikiwe University
Teaching Hospital (NAUTH), Nnewi, South-east, Nigeria,
between 1
st of January, 1998 and 31
st of December, 2009
(a 12 - year period). The case files of 11 women that pre-
sented with vulvar carcinoma and were managed at the
Nnamdi Azikiwe University Teaching Hospital, Nnewi
from the 1st of January, 1998 to the 31
st of December,
2009 were retrieved and studied retrospectively. Thorough
scrutinies of the gynecology ward and theatre unit records
were done to identify these patients. The total number of
gynecological malignancies over the same period was also
obtained. Also, the total number of women that presented
with gynecological problems during the study period was
determined.
Ethical clearance was obtained from the ethical commit-
tee of the Nnamdi Azikiwe University Teaching Hospital,
Nnewi, Nigeria prior to the collection of the case notes.
These case-records were studied and variables such as age,
parity, clinical presentation, stage of disease, type of sur-
gery, histologic type of vulvar carcinoma and complica-
tions of treatment were collected on a data extraction
form and were subsequently analyzed. Where a patient
had surgery, the above information was confirmed by
comparison with information in the operating theatre
record books. All the patients had histologically proven
vulvar carcinoma, though details of histological diagnosis
were not included in this study. Epi-info version 3.3.2 was
used in computing the data into percentages. A p-value of
<0.05 at 95% confidence interval was taken as significant.
Results
During the period of study, there were 11 women
admitted into the gynecological unit with vulvar carci-
nomas. There were a total of 867 gynecological cancers
over the 10 year study period. The total number of
patients admitted to the gynecological unit during the
same period was 3,418. Thus 25.4% of the gynecologic
admissions were for gynecological cancers and 1.27% of
the gynecological cancers were vulvar carcinomas. The
largest numbers of vulvar cancers occurred in the fifth
to seventh decades of life; 82.7% of the cancers occurred
in these age groups. The ages of patients studied ranged
from 54 to 79 years and the mean age for vulvar carci-
noma was 61.2 years. The parity of the women treated
ranged from 2-14. The mean parity of the women trea-
ted was 6.7± 2.33. Most of the patients were of low
socio-economic class.
Clinical presentation (Table 1)
All the patients that presented with vulvar carcinoma
presented with symptoms. Some patients presented with
more than one symptom. Nine (26.4%) of the patients
presented with pruritus vulvae, while 5(14.7%) of the
patients presented with vulvar swelling/vulvar mass.
Histological type of vulvar carcinoma
The commonest histological type of vulvar carcinoma
noted among the 11 patients that presented with vulvar
carcinoma was squamous cell carcinoma, seen in 7(63.6%)
of the patients. There was one (9.1%) case of Bartholin’s
gland adenocarcinoma and one case (9.1%) of basal cell
carcinoma of the vulva. A case (9.1%) of Paget’s disease of
t h ev u l v aa n d1c a s eo fas a r c o m ao ft h ev u l v aw e r ea l s o
noted. No cases of verrucous carcinoma, melanoma, lym-
phomas or metastatic disease to the vulva were noted.
Surgical treatment options offered (Table 2)
The surgical treatment for the various stages of vulvar
carcinomas offered to the patients ranged from wide
local excision to radical vulvectomy. One patient had
wide local excision for vulvar carcinoma, and 2(18.2%)
Table 1 The Presenting symptoms of patients with vulvar
carcinoma
Symptom Frequency Percentage (%)
Pruritus vulvae 9 26.4
Vulvar swelling/lump 5 14.7
Vulvar discharge 5 14.7
Vulvar pain 6 17.8
Urinary tract symptoms 2 5.9
Vulvar bleeding 7 20.5
Total 34 100.0%
*Some patients presented with more than one symptom.
Eke et al. World Journal of Surgical Oncology 2010, 8:94
http://www.wjso.com/content/8/1/94
Page 2 of 6of the women had hemi-vulvectomy. One woman had a
simple vulvectomy. Six of the patients had radical vul-
vectomy as surgical treatment for vulvar carcinoma.
One patient had excision of the Bartholin’s gland.
Complications of treatment (Table 3)
Some of the patients that had treatment for vulvar carci-
noma developed complications from the treatment. One
patient developed an anesthetic complication (Mendel-
son’s syndrome). Two (18.2%) of the patients developed
lymphocysts and 1 woman had chronic lymphedema as
a complication of surgical treatment. One of the patients
developed secondary wound infection.
Stage at presentation
Of the women who had vulvar carcinoma, 1(9.1%) pre-
sented with stage IB, 1(9.1%) with stage II, 5(45.4%)
with stage III and 4(36.4%) with stage IV disease.
Discussion
Vulvar cancers constituted 1.27% of all gynecological
admissions from this study. This is low when compared
to a study in Ghana, where vulvar carcinomas consti-
tuted 2.21% of all gynecological malignancies [7]. The
mean age for vulvar carcinoma from this study - 61.2
years, is within the normal age range for vulvar carcino-
mas when one considers the fact that even early invasive
carcinoma of the vulva is known to be most common in
the late fifties and early sixties. Indeed, in the series
from Zimbabwe, all but one of the 31 patients with vul-
var carcinoma were older than 55 years [8]. It may be
mentioned, however, that a mean age of 43.8 years was
reported from Jamaica about forty years ago [9] and two
patients with vulvar carcinoma in the study done in
Nigeria 20 years ago were in the 40-49 years group [6].
Women in Nnewi, Nigeria with vulvar cancer often
present late for treatment, perhaps because some of
them are not well informed about the disease and the
need to present early. The women in this study were
from the low socio-economic group and had no formal
education. This might have been the reason why they
presented late for treatment with advanced vulvar can-
cer. As was noted, 9 of the 11 women presented for the
first time with at least, stage III disease. Again, even
when they present for treatment, the very elderly ones
are usually reluctant to be physically examined. These
are all challenges to diagnosis and treatment of this dis-
ease in Nnewi, Nigeria.
The majority of the women in this study presented
with stage III vulvar carcinoma (45.4%). Some clinicians
may fail to recognize vulvar carcinoma when patients
present to the hospital in very early stages because of
the vague nature of the symptoms and rarity of vulvar
cancer. It is possible that even when some of these
women present early enough to physicians, the correct
diagnosis may not made on time. Hence, they may pro-
gress to late stages of the disease before the correct
diagnosis is made. It is of note here that the staging sys-
tem used for vulvar carcinoma in this study was the
FIGO staging system of 1988, (since all the cases had
been diagnosed and treated before the new 2009 FIGO
staging system was officially released). A new FIGO sys-
tem for vulvar carcinoma was just adopted by the FIGO
committee on gynecologic oncology in 2009 [10]. The
new FIGO system of staging vulvar carcinomas empha-
sized the importance of lymph node metastasis in the
staging, treatment and prognosis of vulvar carcinomas.
The commonest symptom of vulvar carcinoma from
this study was pruritus vulvae (seen in 26.4% of the
patients). Other symptoms of vulvar carcinoma include
vulvar bleeding, vulvar swelling, ulceration, pain or
burning sensation and vaginal/vulvar discharge [11,12].
The patients studied presented with chronic vulvar itch-
ing, vulvar bleeding, discharge, vulvar swelling and
symptoms of lower urinary tract infection. Vulvar carci-
noma is usually asymptomatic in up to 5% of cases,
where it may be detected histologically in association
with vulvar intra-epithelial Neoplasia (VIN) or carci-
noma of the cervix or anus [7]. On examination, the
Table 2 Surgical treatments offered to patients with
vulvar carcinoma
Surgical treatment Frequency Percentage (%)
Wide local excision 1 9.1
Simple vulvectomy 1 9.1
Hemi - vulvectomy 2 18.2
Radical vulvectomy 6 54.5
Pelvic exenteration 0 0.0
Excision of the Bartholin’s 1 9.1
Total 11 100.0%
Table 3 Complications of surgery
Complication Frequency Percentage (%)
Anesthetic 1 9.1
Hemorrhage 2 18.2
Hematoma 1 9.1
Infection 1 9.1
Necrosis of skin flaps 0 0.0
Deep venous thrombosis 0 0.0
Pulmonary embolism 0 0.0
Lymphocyst formation 2 18.2
Chronic lymphedema 1 9.1
Urinary/fecal incontinence 0 0.0
Introital stenosis 1 18.2
Total 9 100.0%
*Some patients had more than one complication.
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raised or rolled edges [11,12] as was seen in the patients
in this study with advanced disease.
Metastatic disease to the regional inguino-femoral
lymph nodes is the most important factor determining
survival. The depth of invasion of the primary tumor is
the most important factor for predicting nodal involve-
ment. When the depth of invasion is between 1 and
2 mm, the incidence of positive nodes is 8% [2,11]. This
rises to 30% if the depth of invasion is between 3 and 5
mm [3,11]. Lymphadenectomy was not done in the
patient that presented with basal cell carcinoma of the
vulva because the lymph node biopsy result was nega-
tive. Also, it is known that basal cell vulvar carcinoma
rarely metastasize to the regional lymph nodes. Sec-
ondly, the morbidity associated with lymph node dissec-
tion may be high. These were justifications for treating
the patient that presented with basal cell carcinoma
with wide local excision without lymph node dissection.
However, in patients with advanced vulvar carcinoma,
radical vulvectomy and bilateral lymphadenectomy was
done.
Wide local excision involves using a circumferential
incision to remove the cancer and some of the normal
tissue around the cancer. This was the treatment of
c h o i c eo f f e r e dt ot h ep a t i e n tt h a tp r e s e n t e dw i t hb a s a l
cell carcinoma. The patient was placed in the lithotomy
position, cleaned with chlorhexidine solution and
draped. Local infiltration was done using 10 mls of 1%
lignocaine around the area the ulcer was located on the
upper portion of the right labia majora. Vulval skin exci-
sion lines were marked, and a 2 cm margin of normal
skin surrounding the lesion was taken with the incision.
The raw surfaces were closed. The post-operative condi-
tion was satisfactory.
Vulvar biopsy is usually carried out in the clinic under
local anesthesia. In lesions that are 2 cm or less, a wide
local excision biopsy is appropriate but should include a
surrounding 2 cm zone of normal tissue [11,12]. In
large ulcerated lesions, biopsies should be taken from
the edge of the tumor and should include some normal
skin [4]. Diagnosis of the tumor in these patients was
based upon a representative biopsy that included an
area where there was a transition of normal to malig-
nant tissue. Biopsy specimens were taken from the vulva
in all the 11 women that presented with vulvar cancer
for histological diagnosis prior to the definitive treat-
ment they had. Biopsies collected from these women
were of sufficient size to allow differentiation between
superficially invasive and frankly invasive vulvar tumors.
Vulvar biopsies are very important prior to treatment
because they help to determine the extent of disease
spread, as well as the histological type of the vulvar can-
cer [12-15]. Occasionally, an alternative strategy might
be considered. In certain situations where the clinical
diagnosis is apparent and the patient is very sympto-
matic, like in heavy bleeding and or in severe pain, defi-
nitive surgery for the vulvar lesion may be performed.
However, in such situations, biopsy with frozen sections
is recommended prior to proceeding with any radical
procedure. There was no need to do frozen sections on
any of the vulvar specimens collected in this study
because the definitive diagnoses of vulvar cancer in
these patients were already made histologically prior to
surgery.
The vulvar cancer patients that were managed in this
study were generally elderly women. These patients often
have co-morbidities, so a pre-operative anesthetic assess-
ment can be invaluable. The women that presented with
vulvar cancer in this study had pre-operative assessment
by the anesthetists’ a day prior to surgery to determine
their fitness for surgery. Pre-operative investigations that
were done for them included full blood count, serum bio-
chemistry, chest X-ray and electrocardiogram. All these
investigations were done for the patients because majority
of them were elderly. One of the women developed aspira-
tion pneumonitis (Mendelson’s syndrome) as a complica-
tion of general anesthesia. This was however, managed in
the intensive care unit and the patient recovered fully.
Radical vulvectomy and bilateral inguinal lymphade-
nectomy was done for 6 of the women that presented
with advanced disease. We inserted Foley catheter into
the bladder for continuous drainage after surgery. The
wounds were assessed during surgery to determine
whether they could be closed without tension by mobiliz-
ing adjacent tissue. All our radical surgeries were closed
s a t i s f a c t o r i l ys i n c ew ew e r ea b l et om o b i l i z et h et i s s u e s
around the vulva. Radical vulvectomy was associated with
physical morbidity in 4 patients. Two of the patients
developed lymphocysts. The lymphocysts were treated by
marsupialization. The patient with lymphedema was trea-
ted with external compression stockings. She was also
advised about rest, exercise, skin care and massage.
Extensive excisions can create difficulties with primary
wound closure, leading to wound dehiscence, extensive
scarring and disfigurement, discomfort, depression and
loss of sexual function [11]. Hence, in the 6 patients that
had radical vulvectomy, frank and open discussions with
the patients and their families was essential at every stage
of treatment to establish the patients’ wishes as well as to
determine treatment intent in the light of the likely
prognosis.
Butterfly incisions have been used for the treatment of
vulvar carcinoma in the past. In 1981, Hacker et al [12]
showed that, for patients with stage I and II disease, sur-
vival using a triple incision technique was equal to the
butterfly incision with reduced morbidity. Surgery
through the triple incision is now the gold standard
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studies [12]. In stage IA tumors, the risk of nodal metas-
tases is virtually zero. Therefore, the tumor can be
removed by wide local excision with a 2 cm margin of
normal tissue. Groin node dissection should be avoided
if there is less than 1 mm of invasion. For early vulvar
cancers (stage IB and II), a wide local excision down to
the perineal fascia is acceptable. However, if the disease
is multifocal, a wider excision will be required. It should
be noted that the triple incision technique is used to
accommodate inguinal lymph node removal.
The use of pre-operative radiotherapy and chemother-
apy may shrink a vulvar tumor to allow less destructive
surgery, in particular, preservation of sphincters and
avoidance of stomas in stages III and IV carcinomas of
the vulva, especially of the squamous type. These were
not done in the patients that presented with stage III
and IV diseases because the tumors were excised with-
out much difficulty and the sphincters were avoided
satisfactorily. These patients were sent for adjuvant
radiotherapy after surgery. One of the women had a left
hemi-vulvectomy because the mass was completely lim-
ited to the left vulva.
It must also be noted that following surgical treatment
of vulvar carcinoma in this study, the vulvar tissues
excised were sent for histology. It was not possible to
do human papilloma virus (HPV) testing on the tissues
because the facilities for testing vulvar tissues for HPV
are not readily available in Nigeria. Only very few teach-
ing hospitals in Nigeria, like University College Hospital,
Ibadan, Nigeria; Ahmadu Bello University Teaching hos-
pital, Zaria, Nigeria; University of Lagos Teaching Hos-
pital, Nigeria and National Hospital, Abuja, Nigeria have
the facilities to test for HPV. Even in these centers,
there are very few histopathologists who carry out these
procedures.
This study was conducted in one of the tertiary refer-
ral centers in south-eastern Nigeria. One limitation of
this study was that it was conducted in one tertiary cen-
ter in Nigeria. However, the fact that this tertiary center
is among the biggest referral centre in south-eastern
Nigeria makes it a worthwhile study. Patients with gyne-
cological cancer are referred to the Obstetrics and
Gynaecology department of the hospital from all parts
of the country. The hospital receives and manages com-
plicated cases mis-managed by traditional healers from
all parts of Nigeria. Up till 2010, there are no functional
facilities for radiation therapy in south-eastern Nigeria.
Women with advanced vulvar carcinoma who need
radiotherapy are referred to one of any three centers in
the country where they can receive treatment - the
south-western part of Nigeria (Lagos or Ibadan) or the
northern part of the country (Abuja or Zaria). However,
majority of them do not go for this treatment because
they cannot afford it.
Conclusion
Vulvar carcinoma is a rare gynecologic malignancy. The
malignancy is amenable to treatment if patients present
early enough. Currently, most radiotherapy machines in
Nigeria are non functional. Since most of the patients
with vulvar carcinoma present in advanced stages of the
disease, management becomes difficult. Hence, reducing
morbidity associated with treatment without compro-
mising on cure rates remains a challenge.
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